Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Jevtana

Cabazitaxel

Open in the dashboard

Part D claims

197

Prescriptions dispensed, refills included

Drug cost

$2,906,918

Paid at the pharmacy, in all

Prescribers

13

With 11 or more claims of it

In 2024, Medicare Part D recorded 197 claims for Jevtana (cabazitaxel) from 13 prescribers, at a total drug cost of $2.9 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 9 states and territories
Part D claims for Jevtana by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
NY 5 67 $879,441
MA 1 29 $421,183
CA 1 17 $250,227
NJ 1 16 $217,860
TX 1 16 $207,601
PA 1 14 $404,645
FL 1 14 $184,604
LA 1 13 $182,538
VI 1 11 $158,820

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 3 of 3
Part D claims for Jevtana by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 9 147 $2,020,347
Medical Oncology 3 36 $481,926
Nurse Practitioner 1 14 $404,645

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 13 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Debashish Misra Hematology-Oncology MA 29 $421,183 None on record
Jotika Thompson Hematology-Oncology CA 17 $250,227 None on record
Gardith Joseph Hematology-Oncology NY 17 $227,833 None on record
Waqas Rehman Hematology-Oncology NJ 16 $217,860 None on record
Steven Gruenstein Hematology-Oncology NY 16 $216,138 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See all 13 in the dashboard with a free account

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record